PER-082-02已完成未知
CLINICAL TRIAL, CROSS, RANDOMIZED, DOUBLE BLIND, CONTROLLED AGAINST PLACEBO USING VALACICLOVIR TO REMOVE THE EXCRETION OF SIMPLE HERP VIRUS (VHS) AND HUMAN IMMUNODEFICIENCY VIRUSES (HIV) IN INDIVIDUALS COINFECTED WITH HIV TYPE 1 AND VHS TYPE 2.
GLAXOSMITHKLINE RESEARCH TRIANGLE PARK,0 个研究点目标入组 0 人开始时间: 2002年12月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Be over 18 years of age.
- •Be documented HIV-1 positive.
- •Have a CD4 count greater than 200.
- •Not receiving antiretroviral therapy for HIV.
- •Be positive VHS-2 determined by the EIA test (IN> 3.5).
- •Do not intend to travel or emigrate during the time the study lasts.
排除标准
- •■ Known history of adverse reactions to valacyclovir, aciclovir or famciciovir.
- •■ Plan the open use of Aciclovir, valaciclovir, or famciciovir.
- •■ History of seizures.
- •■ Renal insufficiency or serum creatinine> 2.0 mg / dl.
- •■ Hematocrit less than 30%.
研究者
相似试验
招募中
3 期
CLINICAL TRIAL, DOUBLE-BLIND, RANDOMIZED, COMPARED WITH PLACEBO TO EVALUATE THE EFFICACY AND SAFETY OF HYDROXOCOBALAMIN (VITAMIN B12) 10,000 MCG + THIAMINE HYDROCHLORIDE (VITAMIN B1) 100 MG + PYRIDOXINE HYDROCHLORIDE (VITAMIN B6) 50 MG (BEDOYECTA® TRI), COMBINATED WITH STANDARD OF CARE TREATMENT IN PATIENTS WITH CHRONIC LOW BACK PAIN.M545 Low back painLow back painM545PER-040-21aboratorios Grossman S.A.131
已完成
不适用
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes.PER-081-02FAMILY HEALTH INTERNATIONAL, HPTN CORE,
进行中（未招募）
1 期
CLINICAL TRIAL RANDOMIZED, DOUBLE-BLIND CONTROLLED, PHASE III, TO EVALUATE THE USE OF PLATELET RICH PLASMA IN FRONT HYALURONIC ACID IN COXARTHROSIS.coxarthrosisMedDRA version: 18.0Level: PTClassification code 10058417Term: Hyaluronic acidSystem Organ Class: 10022891 - InvestigationsEUCTR2014-004120-21-ESFUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD70
进行中（未招募）
1 期
SEARCH THE optimal time interval between ethyl Triptorelin and follicular puncture IN THE TREATMENT OF IN VITRO FERTILIZATIOINFERTILITYEUCTR2012-005571-14-ESINSTITUTO DE INVESTIGACION SANITARIA LA FE176
进行中（未招募）
不适用
Crossover clinical trial, randomized, double blind, placebo controlled trial. Modulation of cellular mediators and repair endothelial damage in patients with chronic renal disease through inhibition of xanthine oxidase.Patients with chronic kidney disease and asymptomatic hyperuricemia on the balance of mechanisms of vascular injury and repair.MedDRA version: 16.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849EUCTR2013-001640-56-ESFundación Para la Investigación Biomédica de Córdoba